Kestra Medical Technologies, Ltd. Common Stock KMTS Income Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $24.55M+8.8% | $22.57M+16.5% | $19.37M+12.4% | $17.23M+14.2% | $15.09M+2.6% | ||
| $11.65M+4.5% | $11.14M+5.9% | $10.52M+9.6% | $9.6M+12.4% | $8.54M-3.8% | ||
| $12.91M+13.0% | $11.42M+29.1% | $8.85M+16.0% | $7.63M+16.6% | $6.55M+12.3% | ||
| 52.6%+1.9pp | 50.6%+4.9pp | 45.7%+1.4pp | 44.3%+0.9pp | 43.4%+3.8pp | ||
| $4.97M+1.9% | $4.88M+21.9% | $4M-25.7% | $5.39M+60.6% | $3.35M-4.4% | ||
| $42.7M+11.5% | $38.3M+13.6% | $33.73M-33.2% | $50.46M+112% | $23.8M+10.9% | ||
| $47.67M+10.4% | $43.18M+14.4% | $37.73M-32.4% | $55.85M+106% | $27.15M+8.7% | ||
| $47.67M+10.4% | $43.18M+14.4% | $37.73M-32.4% | $55.85M+106% | $27.15M+8.7% | ||
| -$34.77M-9.5% | -$31.76M-10.0% | -$28.88M+40.1% | -$48.21M-134% | -$20.6M-7.7% | ||
| -141.6%-0.9pp | -140.7%+8.4pp | -149.1%+131pp | -279.8%-143pp | -136.5%-6.4pp | ||
| $1.89M-0.7% | $1.9M-0.6% | $1.91M+8.6% | $1.76M-1.3% | $1.78M-23.0% | ||
| $2.16M+20.4% | $1.8M-17.1% | $2.17M+30.9% | $1.66M+164% | $628K-28.5% | ||
| $359K+140% | -$891K-131% | $2.83M+205% | -$2.69M-18,053% | $15K+138% | ||
| -$34.13M-4.2% | -$32.75M-27.0% | -$25.79M+49.4% | -$51.01M-135% | -$21.74M-5.5% | ||
| $35K+2.9% | $34K+3.0% | $33K-67.6% | $102K+467% | $18K+125% | ||
| -$34.17M-4.2% | -$32.79M-26.9% | -$25.83M+50.4% | -$52.05M-142% | -$21.51M-5.6% | ||
| -139.2%+6.1pp | -145.3%-12.0pp | -133.3%+169pp | -302.1%-160pp | -142.5%-4.1pp | ||
| —— | —— | —— | $3.29M-1.0% | $3.32M0.0% | ||
| -$0.61+4.7% | -$0.64-28.0% | -$0.50+68.2% | -$1.57-25.6% | -$1.25-5.0% | ||
| -$0.61+4.7% | -$0.64-28.0% | -$0.50+68.2% | -$1.57-25.6% | -$1.25-5.0% | ||
| 55.8M+8.7% | 51.4M+0.1% | 51.3M+109% | 24.6M+23.6% | 19.9M0.0% | ||
| 55.8M+8.7% | 51.4M+0.1% | 51.3M+109% | 24.6M+23.6% | 19.9M0.0% | ||
| $359K+140% | -$891K-131% | $2.83M+205% | -$2.69M-18,053% | $15K+138% | ||
| $24.55M+8.8% | $22.57M+16.5% | $19.37M+12.4% | $17.23M+14.2% | $15.09M+2.6% | ||
| -$34.77M-9.5% | -$31.76M-10.0% | -$28.88M+40.1% | -$48.21M-134% | -$20.6M-7.7% | ||
| -$32.78M-11.6% | -$29.38M-9.4% | -$26.85M+42.1% | -$46.38M-148% | -$18.71M-8.4% | ||
| -$32.78M-11.6% | -$29.38M-9.4% | -$26.85M+42.1% | -$46.38M-148% | -$18.71M-8.4% | ||
| -133.5%-3.3pp | -130.2%+8.4pp | -138.6%+131pp | -269.1%-145pp | -124%-6.6pp | ||
| -$34.77M-9.5% | -$31.76M-10.0% | -$28.88M+40.1% | -$48.21M-134% | -$20.6M-7.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Kestra Medical Technologies, Ltd. Common Stock's revenue?
- Kestra Medical Technologies, Ltd. Common Stock (KMTS) generated $83.7M in revenue over the trailing twelve months, up 69.0% year over year.
- Is Kestra Medical Technologies, Ltd. Common Stock profitable?
- Kestra Medical Technologies, Ltd. Common Stock is not currently profitable: it reported a net loss of $144.8M over the trailing twelve months, a -173.0% net margin.
- What are Kestra Medical Technologies, Ltd. Common Stock's profit margins?
- Gross margin is 48.8% and operating margin is -171.5%, with a -173.0% net margin.
- What is Kestra Medical Technologies, Ltd. Common Stock's earnings per share?
- Kestra Medical Technologies, Ltd. Common Stock's diluted EPS over the trailing twelve months is $-3.32.
- Where does Kestra Medical Technologies, Ltd. Common Stock's income statement data come from?
- Every line is extracted from Kestra Medical Technologies, Ltd. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
